Current applications of evolving methodologies in gastroesophageal reflux disease testing

Digestive and Liver Disease

Volumn 43, Issue 5, 2011, Pages 353-357

  Weber, Cynthia ^a   Davis, Christopher S ^a   Fisichella, P Marco ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

24 h pH monitoring; Gastroesophageal reflux disease (GERD); Multichannel intraluminal impedance pH (MII pH); Wireless capsule pH monitoring

Indexed keywords

AMBULATORY MONITORING; CAPSULE ENDOSCOPY; CATHETER; CLINICAL PRACTICE; ESOPHAGUS FUNCTION; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; METHODOLOGY; MULTICHANNEL INTRALUMINAL IMPEDANCE PH; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; TECHNIQUE; WIRELESS CAPSULE PH MONITORING;

AMBULATORY CARE; CATHETERS; ELECTRIC IMPEDANCE; ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MONITORING, PHYSIOLOGIC;

EID: 79953267470     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2011.01.007     Document Type: Review

References (48)

1. Kahrilas P.J. Clinical practice. Gastroesophageal reflux disease. N Engl J Med 2008, 359:1700-1707.
2. Camilleri M., Dubois D., Coulie B., et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 2005, 3:543-552.
3. Frank L., Kleinman L., Ganoczy D., et al. Upper gastrointestinal symptoms in North America. Prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci 2000, 45:809-818.
4. Brown L.M., Devesa S.S., Chow W.H. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008, 100:1184-1187.
5. Shaheen N., Hansen R., Douglas M., et al. The burden of gastrointestinal and liver diseases. Am J Gastroenterol 2006, 101:2128-2138.
6. Falor W.H., Hansell J.R., Chang B., et al. Outpatient 24-hour esophageal monitoring by pH telemetry. Gastroenterology 1980, 78:1163-1168.
7. Patti G., Diener U., Tamburini A., et al. Role of esophageal function tests in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 2001, 46:597-602.
8. Campos G.M.R., Peters J.H., DeMeester T.R., et al. Multivariate analysis of the factors predicting outcome after laparoscopic Nissen fundoplication. Gastroenterology 1998, 114:A1381.
9. Patti M., Arcerito M., Massimo T., et al. Effect of laparoscopic fundoplication on gastroesophageal reflux disease-induced respiratory symptoms. J Gastrointest Surg 2000, 4:143-149.
10. Gastal O.L., Castell J.A., Castell D.O. Frequency and site of gastroesophageal reflux in patients with chest symptoms. Studies using proximal and distal pH monitoring. Chest 1994, 106:1793-1796.
11. Davis C., Shankaran V., Kovacs E.J., et al. Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment. Surgery 2010, 148:737-745.
12. Lau C.L., Palmer S.M., Howell D.N., et al. Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc 2002, 16:1674-1678.
13. Cantu E., Appel J.Z., Hartwig M.G., et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004, 78:1142-1151.
14. Burton P.R., Button B., Brown W., et al. Medium-term outcome of fundoplication after lung transplantation. Dis Esophagus 2009, 22:642-648.
15. Schindlbeck N., Heinrich C., Konig A., et al. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 1987, 93:85-90.
16. Vitale G., Sadek S., Tulle M., et al. Computerized 24-hour esophageal pH monitoring: a new ambulatory technique using radiotelemetry. J Lab Clin Med 1985, 105:686-693.
17. Johnsson F., Joelsson B., Isberg P.E. Gut 1987, 28:1145-1150.
18. Mattioli S., Pilotti V., Spangaro M., et al. Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 1989, 34:71-78.
19. Franzen T., Grahn L.T. Reliability of 24-hour oesophageal pH monitoring under standardized conditions. Scand J Gastroenterol 2002, 37:6-8.
20. Ayazi S., Hagen J.A., Zehetner J., et al. Proximal esophageal pH monitoring: improved definition of normal values and determination of a composite pH score. J Am Coll Surg 2010, 210:345-350.
21. Khoury R., Camaco-Lobato L., Katz P., et al. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol 1999, 94:2069-2073.
22. Fass R. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Clin Cornerstone 1999, 37:849-856.
23. Wong W.M., Bautista J., Dekel R., et al. Feasibility and tolerability of transnasal/per-oral placement of wireless pH capsule vs traditional 24-h oesophageal pH monitoring - a randomized trial. Aliment Pharmacol Ther 2005, 21:155-163.
24. Pandolfino J.E., Richter J.E., Ours T., et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003, 98:740-749.
25. Des Varannes S.B., Mion F., Ducrotte P., et al. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut 2005, 54:1682-1686.
26. Scarpulla G., Camilleri S., Galante P., et al. The impact of prolonged pH measurements of the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 2007, 102:2642-2647.
27. Hakanson B., Berggren P., Granqvist S., et al. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal monitoring. Scand J Gastroenterol 2009, 44:276-283.
28. Pandolfino J.E., Lee T.J., Schreiner M.A., et al. Comparison of esophageal acid exposure at 1cm and 6cm above the squamocolumnar junction using the Bravo pH monitoring system. Dis Esophagus 2006, 19:177-182.
29. Kahrilas P.J., Lin S., Chen J., Manka M. The effect of hiatus hernia on gastro-esophageal junction pressure. Gut 1999, 44:476-482.
30. Wenner J., Johnsson F., Johansson J., Oberg S. Acid reflux immediately above the squamocolumnar junction and in the distal esophagus: simultaneous pH monitoring using the wireless capsule pH system. Am J Gastroenterol 2006, 101:1734-1741.
31. Fajardo N.R., Wise J.L., Locke G.R., et al. Esophageal perforation after placement of wireless Bravo pH probe. Gastrointest Endosc 2006, 63:184-185.
32. Fischer A., Baier P.K., Utzolino S., et al. Management of severe chest pain caused by a Bravo pH monitoring capsule. Endoscopy 2008, 40:E55-E56.
33. Triester S.L., Leighton J.A., Budavari A.I., et al. Severe chest pain from an indwelling Bravo pH probe. Gastrointest Endosc 2005, 2:317-319.
34. Tharavej C., Hagen A., Portale G., et al. Bravo capsule induction of esophageal hypercontractility and chest pain. Surg Endosc 2006, 20:783-786.
35. Hila A., Agrawal A., Castel D.O. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol 2007, 5:172-177.
36. Bredenoord A.J., Weusten B., Timmer R., et al. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006, 101:453-459.
37. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006, 55:1398-1402.
38. Zerbib F., Roman S., Ropert A., et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006, 101:1956-1963.
39. Richter J. Con: Impedance-pH testing does not commonly alter management of GERD. Am J Gastroenterol 2009, 104:2667-2669.
40. Vela M., Camacho-Lobato L., Srinivasan R., et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001, 120:1599-1606.
41. Sifrim D. Relevance of volume and proximal extent of reflux in gastroesophageal reflux disease. Gut 2005, 54:175-178.
42. Zerbib F., des Varannes S., Bruley R., et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005, 22:1011-1021.
43. Garrean C., Zhang Q., Gonsalves N., Hirano I. Acid reflux detection and symptom-reflux association using a 4-day wireless pH recording combining 48-hour periods off and on PPI therapy. Am J Gastroenterol 2008, 103:1631-1637.
44. Wiener G.J., Richter J.E., Cooper J.B., et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988, 83:358-361.
45. Breumelhof R., Smouth A.J. The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991, 86:160-164.
46. Weusten B.L., Rolfs J.M.M., Akkermans L.M.A., et al. The symptom association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994, 107:1741-1745.
47. Taghavi S.A., Ghasedi M., Saberi-Firoozi M., et al. Symptom association probability and symptom index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 2005, 54:1067-1071.
48. Hirano I., Richter J.E. ACG Practice Guidelines: esophageal reflux testing. Am J Gastroenterol 2007, 102:668-685.